Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 20, Number 11—November 2014
Research

Seroprevalence of Norovirus Genogroup IV Antibodies among Humans, Italy, 2010–2011

Barbara Di MartinoComments to Author , Federica Di Profio, Chiara Ceci, Elisabetta Di Felice, Kim Y. Green, Karin Bok, Simona De Grazia, Giovanni M. Giammanco, Ivano Massirio, Eleonora Lorusso, Canio Buonavoglia, Fulvio Marsilio, and Vito Martella
Author affiliations: Università degli Studi di Teramo, Teramo, Italy (B. Di Martino, F. Di Profio, C. Ceci, E. Di Felice, F. Marsilio); National Institutes of Health, Bethesda, Maryland, U.S.A. (K.Y. Green, K. Bok); Università degli Studi di Palermo, Palermo, Italy (S. De Grazia, G.M. Giammanco); Azienda USL di Reggio Emilia, Reggio Emilia, Italy (I. Massirio); Università Aldo Moro di Bari, Valenzano, Italy (E. Lorusso, C. Buonavoglia, V. Martella)

Main Article

Table

Seroprevalence of IgG antibody against norovirus GIV.1 and GIV.2 in human serum specimens, Italy, 2010–2011*

NoV GIV virus-like particles
 Serum dilutions
 Total (%)
1:200 (%)
 1:400 (%)
GIV.1 78 (14.5) 40 (7.4) 118/535 (22.0)
GIV.2 12 (2.2) 14 (2.6) 26/535 (4.8)
GIV.1+GIV.2 3 (0.5) 4 (0.7) 7/535 (1.3)

*GIV; genogroup IV; NoV, norovirus.

Main Article

Page created: October 15, 2014
Page updated: October 15, 2014
Page reviewed: October 15, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external